Life Sciences

7 Companies Doing DNA Synthesis for Medical R&D

One of the important figures behind deoxyribonucleic acid (DNA) synthesis technology is biochemist and Nobel Laureate Kary Mullis. Allegedly, he discovered a way to synthetically replicate DNA through what is now known as polymerase chain reaction (PCR) while dropping massive hits of acid on his way home from work. And despite the massive potential behind […]

Science 37 Stock for Decentralized Clinical Trials

Nothing like a pandemic to illuminate a thing or two about human nature. For example, people apparently spend way too much time wiping their butts. Or, at the very least, are very inefficient in their use of toilet paper. We also learned quite a bit about clinical trials, though the COVID-19 vaccine studies were atypical […]

Babylon Health Stock: Value-Based Care Using Telehealth

Last year, we judged Teladoc (TDOC) as the best investment into the telehealth theme – and that was just a few months before the company’s $18.5 billion blockbuster acquisition of Livongo, which developed an AI platform for managing chronic diseases like diabetes. The business model is all about providing services virtually through apps, chats, and […]

9 Neurotechnology Companies Merging Humans and Machines

The days of living inside a biological human shell are almost over. At least that’s what futurists are hoping for, as we roll out more advanced neurotechnology that allows humans to interface directly with machines. It’s possibly both the most exciting and most alarming thing happening in life sciences right now. We previously looked at […]

MaxCyte Stock – Investing in the Future of Cell Therapy

Sometimes our new subscribers will ask for “stock picks,” and we’re quick to explain that’s not how we operate. We manage our own portfolio of tech stocks based on our unique needs and risk profile. Our subscribers, many of whom are professional money managers, derive insights from our research since we document every investment decision […]

How Eikon Uses Fluorescence Microscopy for Drug Discovery

Back in the 1670s, a Dutch cloth merchant by the name of Antonie van Leeuwenhoek invented the first microscopic lens to get a better view of his cloth threads. Using his new invention, he discovered the microscopic world of cells, bacteria, and oddly enough, sperm. He singlehandedly became the father of microbiology. While it’s a […]

6 Billion-Dollar Telehealth Companies to Watch

One of the big challenges over the last year or so – aside from deciding when it was safe to get a haircut again – is teasing out the ephemeral from the existential when it comes to investing in the stock market. We’ve referred to this as the remote connectivity investment thesis. Basically, investors are […]

AI Healthcare Company Offers Software as a Medical Device

It’s probably no surprise that money is pouring into life sciences and healthcare startups during the biggest medical crisis in a century. CB Insights reported that global healthcare funding hit a new record $31.6 billion in this first quarter of 2021. It’s also no shock that the two biggest trends – artificial intelligence and telehealth […]

AbCellera Stock – Turning Antibodies Into Drugs

We believe it’s critically important to only invest in businesses that we understand. If you need a subject matter expert to explain a company’s value proposition, you shouldn’t be invested in it. Yesterday’s article on A Pure-Play LegalTech Stock for FinTech Investors is a great example of a value proposition that’s easy to understand. Today, […]